Brattleboro Memorial Hospital (BMH) is a not-for-profit hospital that provides high quality inpatient, outpatient, and ambulatory services for the communities in the tri-state area of Vermont, New Hampshire, and Massachusetts.

Prostate cancer is the second leading cause of cancer deaths in men (after lung cancer) in the United States.

Prostate cancer often has no early symptoms. Advanced prostate cancer, however, can cause men to urinate more often or have a weaker flow of urine (NOTE: these symptoms can also result from benign prostate conditions). Without routine screening, many men may not realize they have the disease until it has progressed.

Men at average risk should discuss prostate cancer screening with their doctor around the age of 50 years. Earlier discussions, typically around 45 years, may be recommended for those with:

• A family history of prostate cancer
• Certain inherited genetic mutations
• Other high-risk factors

The two most common screening tests are:

• Prostate-Specific Antigen (PSA) Test: This is a simple blood test that measures the level of PSA, a protein produced by prostate cells. A higher-than- normal PSA level may indicate prostate cancer, but it can also be a sign of other prostate conditions.
• Digital Rectal Exam (DRE): In this procedure, a doctor inserts a gloved, lubricated finger into the rectum to feel the prostate for any lumps or abnormal areas.

The decision to screen is a personal one that you should make in consultation with your healthcare provider. Prostate cancer is a serious disease, but one that is highly treatable, especially when caught early. Knowing your risk factors and having open conversations with your doctor about screening are the most powerful steps you can take.

Follow this link to learn more about prostate cancer and prostate cancer screening.